Opiant Pharmaceuticals Inc. (OPNT)

[catty]

Check out Seeking Alpha - the just released the transcript of their conference call. Unfortunately I don't know how to post it.

[catty]

Boston: Congrats.

[BostonSportsNut]

You are very lucky. I'm 33 years clean. Really think at some point this thing is going to save a lot of lives and also make. Us a lot of money.

[catty]

Boton: about time. nice move. I love what they're doing, that's mainly why I'm in the stock. It's such a major problem today - fortunately I've never been on drugs.

[BostonSportsNut]

Saw that! Things are picking up Cat!

[catty]

Boston: check out Seeking Alpha - good coverage on OPNT. This Company is so under the radar. Someone has to either partner or buyout. It's such a hot issue today. Thanks for posting

[BostonSportsNut]

Opiant Pharmaceuticals (NASDAQ:OPNT): Q2 EPS of $0.31 may not be comparable to consensus of -$0.55.

Revenue of $6.78M (+115.2% Y/Y) beats by $2.77M.

[catty]

Sooner or later someone has to discover us

[catty]

With the existing opioid crisis I don't understand why our little company isn't getting the attention it deserves.

[highstreettrader]

https://www.genengnews.com/news/opiant-eyes-q2-launch-for-pivotal-trial-of-opioid-overdose-candidate-aimed-at-fentanyl/

[mark_biwojno]

Opiant Pharma shareholders. Please read my press release: http://www.globenewswire.com/news-release/2019/02/20/1738534/0/en/Medical-Device-Design-Proposal-To-Nasdaq-Listed-Biotech-Company-Hopes-To-Stop-Opioid-Overdose-Deaths.html

Thank you.

[catty]

OPNT is the perfect takeover for a big Pharma company. Amazing the stock isn't moving with all the concerns ansd attention now given to the Opiant problem. It'll soon catch on

[fl89808]

$32 price target on Opiant's shares.
VALUE IN OPIANT AFTER ADAPT DEAL: In a research note to investors, Cantor Fitzgerald's Folkes argued that Emergent BioSolutions' acquisition of Adapt Pharma underscores the value of the opioid overdose market. At a market cap of about $44M, the analyst pointed out he believes Opiant presents an attractive risk/reward, even if it captures only a portion of the growing market. Opiant is expected to generate about $30M-38M in cash from Narcan royalties and the milestone payment in 2019, to fund the development of its own opioid overdose nasal spray, OPNT003, and the other programs in the company's pipeline, he noted. Overall, Folkes said he expects investors to begin to appreciate the market potential of Opiant's pipeline, which should drive the stock higher. The analyst reiterated an Overweight rating and $32 price target on Opiant's shares.

Read more at:
https://thefly.com/landingPageNews.php?id=2783481

https://thefly.com/landingPageNews.php?id=2783481&headline=OPNT;EBS-Opiant-jumps-as-analyst-sees-value-after-opioid-overdose-spray-maker-bought

[catty]

Don't understand why the stock isn't moving up, The CEO was again interviewed on Fox Business this morning. He comes across as extremely credible. I see this company as a perfect takeover by a big Pharma company.

They have the products to fight the Opiant problem.. They are now working on combating the deadly Fentinal (not sure of the spelling) situation

[catty]

Since Opiloids are one of Trump's major concerns, I contacted the WH today advising him of our little company. You never know!

[catty]

fl89808 - Trump just held a conference on the Opiant problem - hopefully OPNT will get the recognition it deserves.

[fl89808]

Based on gross revenues of approximately $250 million in 2019, we estimate that Opiant would receive approximately $34.3 million in royalty and milestone payments (and result in net revenues to Emergent of approximately $215 million). This assumes that sales of NARCAN® Nasal Spray do not exceed $200 million in 2018, as Opiant is owed a $15 million milestone at that threshold.

https://finance.yahoo.com/news/opnt-adapt-pharma-acquired-650-190000844.html

[catty]

Love what they're doing. Surprised the market hasn't really picked it up

[catty]

Check out Seeking Alpha - news.

good idea to sign up with them...they issue up to the minute news on your favorite stocks.

[catty]

looks like a good takeover/merger candidate

[catty]

Great interview today on Fox Business. Just took a position. Helps solve a huge problem today, one of which is very much on Trump's agenda

[BostonSportsNut]

News out tonight

[rikshot]

News out yesterday:

https://ih.advfn.com/p.php?pid=nmona&article=76982350


Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

Prospectus filed to sell up to $20,000,000 worth of OPNT

This looks like dilution at its finest (OUCH)

[stocktrademan]

OPNT buy 23.00

bull flag
high volume
triple bottom
price crossing over the ichimoku cloud
bullish vortex indicator crossup
at support for a low risk high reward trade



https://www.opiant.com/

normal chart




log chart

[MasterSalix]

That’s our licensed vaccine they are talking about:

https://www.cnbc.com/2018/03/19/trumps-new-opioid-plan-supports-addiction-vaccine.html

https://ir.opiant.com/news-releases/news-release-details/opiant-pharmaceuticals-inc-licenses-heroin-vaccine-walter-reed

$$$$$$$$$$$

[Liquid_Bull]

Wow! Up over $12 to a high of over $32... why?

[fl89808]

OPNT: Developing Longer-Acting Opioid Overdose Treatment

https://finance.yahoo.com/news/opnt-developing-longer-acting-opioid-170000858.html

"Based on these adjustments we have raised our valuation from $51 to $55."

[MasterSalix]

CEO was on Fox business - Varney interview...

[fl89808]

This stock shot up $6 at 1140am and I could find no news. Anyone?

[Kizersosae]

From one Opioid investor to another, check out BICX! Today’s PR was big:

1) 505B2 fast track... Green lighted!

2) Dual application for opioids and alcohol treatment... Green lighted!

3) Grants from NIH... Green lighted!

https://finance.yahoo.com/news/biocorrx-announces-results-pre-ind-142318777.html;_ylc=X1MDMTE5Nzc4NDE4NQRfZXgDMQRfeXJpZAM3aHJjYzAxZDgzcnFnBGcDZFhWcFpEeHVjejQzWVRFMk5EQXdOeTB3T0RNd0xUTTVZbUl0T1dabU1DMWlPR0psTVdRNE5XSXpNbUoxZFdsa1BHNXpQa0pKUTFnPQ0KBGxhbmcDZW4tVVMEb3JpZ19sYW5nA2VuBG9yaWdfcmVnaW9uA1VTBHBvcwMwBHJlZ2lvbgNVUwRzeW1ib2wDQklDWA--?.tsrc=applewf

[fl89808]

On February 8, 2018, Opiant Pharmaceuticals, Inc., a Delaware corporation (the “Company”), issued a press release announcing that it will record a total of approximately $11.7 million in royalty and milestone payments for the five-month period ended December 31, 2017 related to full-year 2017 sales of NARCAN® Nasal Spray (“NARCAN”) for opioid overdose by the Company’s commercial partner, Adapt Pharma Operations Limited (“Adapt Pharma”). Going forward, the Company will receive 90% of royalty and milestone payments related to NARCAN sales directly from Adapt Pharma, with its royalty and milestone payment obligations to SWK Funding LLC (“SWK”) being correspondingly reduced to 10%, as SWK has been paid $26.25 million per the terms of that certain Purchase and Sale Agreement, dated as of December 13, 2016, by and between the Company and SWK.

[fl89808]

OPNT will receive 90% of royalty and milestone payments related to NARCAN sales directly from Adapt Pharma.
$$$$$

[avinanyc]

Go OPNT
only less 3m shares
Opiod related

[fl89808]

Opiant Pharmaceuticals Announces Significant Financial Developments Related to NARCAN® Nasal Spray for Opioid Overdose
GlobeNewswire•December 20, 2017

Opiant Expects to Receive 90% of NARCAN Sales-Related Royalty and Milestone Payments, Going Forward

SANTA MONICA, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced that it expects that, beginning in the first quarter of 2018, it will receive 90% of royalty and milestone payments related to NARCAN sales directly from Adapt Pharma. Correspondingly, the royalty and milestone payments due to SWK Holdings will now be reduced to 10%, as they will have been paid the $26.25 million per the royalty monetization agreement between Opiant and SWK.

[fl89808]

EPS -$2.77 just posted for latest quarter.

[TREND1]

Just started to follow OPNT

[BostonSportsNut]

Things are looking up, Cheeto gave a speech, CEO on Fox news, PPS exploded, exciting times.

[fl89808]

Opiant Pharmaceuticals Files $150 Mln Shelf for Stock and Warrants           10/16/2017 16:15 PM EDT        

04:15 PM EDT, 10/16/2017 (MT Newswires) -- Opiant Pharmaceuticals (OPNT) filed to sell up to $150 million in stock and warrants.

[rikshot]

OPNT board screwed up with OPNET skam board----Those of you who made out well in OPNT----OPNT is now in "partnership" with TTNP to use TTNP "Pro-neura platform" for their drugs. TTNP now at $2.00---Will most likely do the same as OPNT---Sell some OPNT & buy into TTNP for another likely big ride. Check it out & you'll probably thank me for this.

[BostonSportsNut]

Thanks Dwayne

[zino]

Christie is a Big Narcan Supporter !!!!

[zino]

Christie Outlines $200 Million Plan to Counter Opioid Crisis
https://www.bloomberg.com/news/articles/2017-09-19/christie-outlines-200m-for-opioids-while-waiting-on-trump

[VERITAS77]

Big Day$ Coming

[zino]

State attorneys general subpoena opioid makers and dealers
https://www.cnbc.com/video/2017/09/19/state-attorneys-general-subpoena-opioid-makers-and-dealers.html

[zino]

Gov. Chris Christie signed legislation making Narcan available without a prescription
http://nj1015.com/narcan-is-saving-thousands-of-nj-lives-and-thats-bad-news/

[zino]

No. 3 Pct. leader On Nasdaq Now

[zino]

No. 5 Pct. leader ....On Nasdaq Radars Now

[zino]

NARCAN® Nasal Spray remains the only U.S. Food and Drug Administration (FDA) approved nasal naloxone product for the emergency treatment of opioid overdose

[zino]

Lets see 40...

[zino]

Bought some today...glta